LVIP State Street Small-Cap Index Fund
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST
Fund classification
Classified from what the fund holds · as of 2026 Q2
LVIP State Street Small-Cap Index Fund is a U.S. equity index fund that tracks the Russell 2000 Index. 29% of LVIP State Street Small-Cap Index Fund’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 85% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Index (passive)
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2025 Q2
The investment objective of the LVIP SSGA Small-Cap Index Fund (the Fund) is to seek to approximate as closely as practicable, before fees and expenses, the performance of the Russell 2000 Index*, which emphasizes stocks of small U.S. companies.
The fund tracks the Russell 2000 Index, which comprises the 2000 smallest companies in the Russell 3000 Index, by holding securities in that index or using stock index futures contracts as substitutes. The fund may omit index constituents when transaction costs are high, liquidity is constrained, or corporate actions are pending, which can cause its returns to diverge from the index.
| Share class | Gross | Net |
|---|---|---|
| C000043863 | 0.39% | 0.38% |
| C000043864 | 0.64% | 0.63% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 13.00% · as of 2025 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.57% |
| Cash & short-term | 0.33% |
| Derivatives | 0.01% |
| Bonds | 0.00% |
Look-through blends 1 underlying fund; 0.013% of NAV was not looked through and stays direct-classified. The blend is as of 2026Q1, one or more quarters before the direct holdings (2026Q2).
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Health Care | 19.4% |
| Financials | 18.0% |
| Industrials | 14.8% |
| Information Technology | 13.8% |
| 10 smaller | 34.1% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
This fund changed legal form during the period shown. The history above is continuous — it spans both eras, and the change is not a gap in reporting.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| MOG/A | Moog IncMOG/A | 0.38% | $423.84 | $8.43M | 19.9K |
| HUT | Hut 8 CorpHUT | 0.37% | $115.45 | $8.28M | 71.7K |
| VSAT | Viasat IncVSAT | 0.35% | $89.81 | $7.89M | 87.9K |
| BTSG | BrightSpring Health Services IncBTSG | 0.35% | $69.74 | $7.89M | 113.2K |
| CYTK | Cytokinetics IncCYTK | 0.35% | $85.19 | $7.81M | 91.7K |
| MXL | MaxLinear IncMXL | 0.34% | $128.03 | $7.69M | 60.0K |
| AGX | Argan IncAGX | 0.34% | $798.55 | $7.61M | 9.5K |
| UMBF | UMB Financial CorpUMBF | 0.33% | $142.76 | $7.32M | 51.3K |
| — | JFrog Ltd | 0.31% | $90.88 | $6.88M | 75.7K |
| RIOT | Riot Platforms IncRIOT | 0.30% | $27.38 | $6.78M | 247.6K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 3.40% of net assets, top 25 7.45%, across 2.0K issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free